IMU imugene limited

0.00%

13.5¢

Imugene Small Caps Presentation, page-59

First 59 Last

Share
Profile

Follow
Graphite101

2,500 Posts.

39

05/04/18

11:17

Post #: 32237710
Share

Originally posted by Few Pennies ↑

Gekkowolf YES GOOD QUESTION
I could just leave my reply to the above line, but figure you would prefer a bit more of an explanation so-

As the other companies all have boards and share holders to whom they are accountable, I'd say they are waiting for more proof of concept, i.e. they need more trial varification first.

However I don't think they will need to be in a mad rush to get to Imugenes door first, as the deal is unlikely to just dissapear in fact if one player comes in for a deal you can be certain that other players on the sidelines would more than likely be alsoinvited to be involved at the negotiating table and not forgotton.

On the whole its all waiting on data,

I have heard of the scientific oversight talking about the strong empiracle evidence (do look that phrase up on google if you don't knowwhat it means) assosiated with the Her-Vaxx mimotope.

but the big Pharma will need at least some next stage proof and it won't make that much differance to them to wait.
Its only the shareholders that don't like to waite and get an answer sooner than ideal ( like a child wantig to open the present before christmas)

So yes timing with this is important and the timing of a deal is valuable, so I would say that in the meantime its in imugenes best interest (and share holders) to wait, the longer the better (within reason, as long as funds don't dry up) because the currant trials will produce more data which will make for a bigger deal.

I think that if the Emperical Scientific Evidence (that has been expressed by a number of people both within and on the outside of this company ) is correct, then its going to be all very good news for both cancer sufferers and share holders alike

FP

Expand

All valid points - we may need another funding round so even if we got one at 3.2c to sophisticated that would set the tone - today could be slow by looks of things

GLTA

IMU Price at posting: 3.6¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Australia's resources and energy exports remain strong, despite Middle East crisis

LISTEN: HotCopper Wire Podcast #052 – Finger lickin' not so good

SNT

Syntara shows encouraging first signals it can impact the path to Parkinson's

The ASX Today: Energy lifts Aussie market as Vault surges on $5.6bn takeover bid

Expert Exchange: David Sokulsky on AI trade, chip stocks, and where to invest now

First 59 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 13.5¢		Change 0.000(0.00%)		Mkt cap ! $56.13M

Open	High	Low	Volume
0.0¢	0.0¢	0.0¢	0

Buyers (Bids)

Vol.	Price($)
178615	13.0¢

Sellers (Offers)

Price($)	Vol.
14.0¢	143853

Last trade - 13.58pm 06/07/2026 (20 minute delay)

IMU (ASX) Chart

Day chart unavailable

Imugene Small Caps Presentation, page-59

Australia's resources and energy exports remain strong, despite Middle East crisis

LISTEN: HotCopper Wire Podcast #052 – Finger lickin' not so good

Syntara shows encouraging first signals it can impact the path to Parkinson's

The ASX Today: Energy lifts Aussie market as Vault surges on $5.6bn takeover bid

Expert Exchange: David Sokulsky on AI trade, chip stocks, and where to invest now

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Imugene Small Caps Presentation, page-59

Top Stories

Australia's resources and energy exports remain strong, despite Middle East crisis

LISTEN: HotCopper Wire Podcast #052 – Finger lickin' not so good

Syntara shows encouraging first signals it can impact the path to Parkinson's

The ASX Today: Energy lifts Aussie market as Vault surges on $5.6bn takeover bid

Expert Exchange: David Sokulsky on AI trade, chip stocks, and where to invest now

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News